Table 4.

Study summary for compounds containing the free form of quindioxins

Compound id	Leadscope id	Name	Study result	Strains tested	Positive tester strain	Reference
52	LS-142960	Quinoxaline	Positive	TA98(2); TA100(2); TA102(2)	TA98 + S9	(71)
52	LS-142960	Quinoxaline	Negative	TA98(3); TA100(3); TA1535(3); TA1537(3); TA1538(3)		(72)
53	LS-1019	2,3-Dichloroquinoxaline	Negative	TA100(6); TA1535(6); TA1537(6); TA98(6)		(73)
53	LS-1019	2,3-Dichloroquinoxaline	Negative	TA98(3); TA100(3); TA1535(3); TA1537(3); TA1538(3)		(74)
53	LS-1019	2,3-Dichloroquinoxaline	Negative	TA100(3); TA1535(3); TA1537(3); TA98(3)		(75)
54	LS-31236	Chlorsulfaquinoxaline	Negative	TA98(3); TA100(3); TA1535(3); TA1537(3); TA1538(3)		(76)
55	LS-143043	2-Methylquinoxaline	Negative	TA98(2); TA100(2); TA102(2)		(71)
56	LS-177484	Brimonidine tartrate	Negative	TA1535(2); TA1537(2); TA1538(2); TA98(2); TA100(2)		(77)
56	LS-177484	Brimonidine tartrate	Negative	TA98(2); TA1537(2); TA1538(2); TA1535(2); TA100(2)		(78)
57	LS-445000	Brimonidine tartrate and timolol maleate	Negative	TA98(4); TA100(4); TA102(4); TA1535(4); TA1537(4)		(79)